Kyle Ritchie

Kyle Ritchie serves as the Director of Business Development at Cellares since June 2023, focusing on advancements in cell therapy manufacturing. Prior experience includes similar roles at OmniaBio, a CCRM subsidiary, and CCRM itself, where Ritchie contributed to the development and commercialization of cell and gene therapies. A notable tenure at Sartorius Stedim Biotech involved managing a portfolio of advanced therapies and spearheading revenue growth for cell culture media services across the Americas. Prior to that, Ritchie held significant roles at Lonza and SciLog, demonstrating expertise in bioprocessing systems and biotechnology sales. Ritchie earned a Bachelor of Science in Materials Science and Engineering and a business certification from the University of Wisconsin-Madison.